optimal anti-reflux barrier
with TIF®* 2.0
*Transoral Incisionless Fundoplication
TIF 2.0 Procedure
TIF 2.0 restores anatomy and reconstructs the gastroesophageal flap valve while maintaining exemplary safety profile with minimal side-effects.
Provide durable relief of GERD symptoms to a broader patient population
The benefits of TIF 2.0 are clear:
- 81% of patients get off daily PPIs1
- No difficulty swallowing2
- No gas bloat syndrome or flatulence2
- Spares the fundus and blood supply of the stomach
Disadvantages of traditional anti-reflux surgery often include:
- Inability to belch or vomit
- Difficulty swallowing
- Increased bloating and flatulence
- Division of the short gastric vessels
- In 11 TIF 2.0 on label studies collectively representing 568 patients where the follow-up was between 7 and 59 months, the weighted incidence percentage of patients completely off PPIs was 73.50%, and 7.91% of the patients reported occasional use of PPIs, for a total of 81.41% of the patients reporting no daily use of PPIs.
- Ihde GM, et al. JSLS. 2019 Jan-Mar;23(1) & Janu, Mavrelis, et al. Abstract ACG 2017 (Concomitant 12-mo).
The omega-shaped gastroesophageal flap valve (GEFV) built with TIF 2.0 does not twist or torque the esophogus as seen in Nissen and other fundoplication techniques.